Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints - PubMed (original) (raw)
. 2006 Nov 30;444(7119):633-7.
doi: 10.1038/nature05268.
Nousin Rezaei, Michalis Liontos, Panagiotis Karakaidos, Dimitris Kletsas, Natalia Issaeva, Leandros-Vassilios F Vassiliou, Evangelos Kolettas, Katerina Niforou, Vassilis C Zoumpourlis, Munenori Takaoka, Hiroshi Nakagawa, Frederic Tort, Kasper Fugger, Fredrik Johansson, Maxwell Sehested, Claus L Andersen, Lars Dyrskjot, Torben Ørntoft, Jiri Lukas, Christos Kittas, Thomas Helleday, Thanos D Halazonetis, Jiri Bartek, Vassilis G Gorgoulis
Affiliations
- PMID: 17136093
- DOI: 10.1038/nature05268
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova et al. Nature. 2006.
Abstract
Recent studies have indicated the existence of tumorigenesis barriers that slow or inhibit the progression of preneoplastic lesions to neoplasia. One such barrier involves DNA replication stress, which leads to activation of the DNA damage checkpoint and thereby to apoptosis or cell cycle arrest, whereas a second barrier is mediated by oncogene-induced senescence. The relationship between these two barriers, if any, has not been elucidated. Here we show that oncogene-induced senescence is associated with signs of DNA replication stress, including prematurely terminated DNA replication forks and DNA double-strand breaks. Inhibiting the DNA double-strand break response kinase ataxia telangiectasia mutated (ATM) suppressed the induction of senescence and in a mouse model led to increased tumour size and invasiveness. Analysis of human precancerous lesions further indicated that DNA damage and senescence markers cosegregate closely. Thus, senescence in human preneoplastic lesions is a manifestation of oncogene-induced DNA replication stress and, together with apoptosis, provides a barrier to malignant progression.
Similar articles
- Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.
Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre' M, Nuciforo PG, Bensimon A, Maestro R, Pelicci PG, d'Adda di Fagagna F. Di Micco R, et al. Nature. 2006 Nov 30;444(7119):638-42. doi: 10.1038/nature05327. Nature. 2006. PMID: 17136094 - Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA. Sarkisian CJ, et al. Nat Cell Biol. 2007 May;9(5):493-505. doi: 10.1038/ncb1567. Epub 2007 Apr 22. Nat Cell Biol. 2007. PMID: 17450133 - Oncogene-induced senescence as an initial barrier in lymphoma development.
Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dörken B, Jenuwein T, Schmitt CA. Braig M, et al. Nature. 2005 Aug 4;436(7051):660-5. doi: 10.1038/nature03841. Nature. 2005. PMID: 16079837 - Oncogene-induced senescence: putting the brakes on tumor development.
Braig M, Schmitt CA. Braig M, et al. Cancer Res. 2006 Mar 15;66(6):2881-4. doi: 10.1158/0008-5472.CAN-05-4006. Cancer Res. 2006. PMID: 16540631 Review. - Tipping the balance: Cdk2 enables Myc to suppress senescence.
Hydbring P, Larsson LG. Hydbring P, et al. Cancer Res. 2010 Sep 1;70(17):6687-91. doi: 10.1158/0008-5472.CAN-10-1383. Epub 2010 Aug 16. Cancer Res. 2010. PMID: 20713526 Review.
Cited by
- The history and future of targeting cyclin-dependent kinases in cancer therapy.
Asghar U, Witkiewicz AK, Turner NC, Knudsen ES. Asghar U, et al. Nat Rev Drug Discov. 2015 Feb;14(2):130-46. doi: 10.1038/nrd4504. Nat Rev Drug Discov. 2015. PMID: 25633797 Free PMC article. Review. - Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer.
Velimezi G, Liontos M, Vougas K, Roumeliotis T, Bartkova J, Sideridou M, Dereli-Oz A, Kocylowski M, Pateras IS, Evangelou K, Kotsinas A, Orsolic I, Bursac S, Cokaric-Brdovcak M, Zoumpourlis V, Kletsas D, Papafotiou G, Klinakis A, Volarevic S, Gu W, Bartek J, Halazonetis TD, Gorgoulis VG. Velimezi G, et al. Nat Cell Biol. 2013 Aug;15(8):967-77. doi: 10.1038/ncb2795. Epub 2013 Jul 14. Nat Cell Biol. 2013. PMID: 23851489 - The DNA damage response and cancer therapy.
Lord CJ, Ashworth A. Lord CJ, et al. Nature. 2012 Jan 18;481(7381):287-94. doi: 10.1038/nature10760. Nature. 2012. PMID: 22258607 Review. - Senescence from G2 arrest, revisited.
Gire V, Dulic V. Gire V, et al. Cell Cycle. 2015;14(3):297-304. doi: 10.1080/15384101.2014.1000134. Cell Cycle. 2015. PMID: 25564883 Free PMC article. Review. - The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced Senescence.
Atkinson C, McInerney-Leo AM, Proctor M, Lanagan C, Stevenson AJ, Dehkhoda F, Caole M, Maas E, Ainger S, Pritchard AL, Johansson PA, Leo P, Hayward NK, Sturm RA, Duncan EL, Gabrielli B. Atkinson C, et al. Int J Mol Sci. 2024 Jan 29;25(3):1664. doi: 10.3390/ijms25031664. Int J Mol Sci. 2024. PMID: 38338943 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous